Skip to main content
Clinical Trials/NCT04765839
NCT04765839CompletedNot Applicable

Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With Minority Populations

Mayo Clinic2 sites in 1 country74 target enrollmentStarted: February 12, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
74
Locations
2
Primary Endpoint
COVID-19 attitudes

Study Overview

Brief Summary

A cluster randomized trial will be conducted prior to widespread vaccine availability to the general public. Community-informed COVID-19 vaccine messages will be disseminated to participants. At baseline, 2 weeks and 4 weeks, the study team will survey participants to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Detailed Description

A cluster randomized trial with 80 participants from the social networks of 8 CLs will be conducted prior to widespread vaccine availability to the general public. Four CLs and social networks (cluster of 10 per network) will be randomly assigned to receive the intervention immediately or after a delay of 2 weeks. Intervention participants will be invited to a closed social media group on the platform of their choice. CLs, selected for trustworthiness within vulnerable populations, will disseminate community-informed COVID-19 vaccine messages to members of their social networks and engage in bidirectional communication with CEnR partners to refine messages. At baseline, 2 weeks and 4 weeks, participants will be surveyed to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Participant)

Masking Description

Randomization outcomes will not be disclosed to participants.

Eligibility Criteria

Ages
18 Years to 101 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Self-identification within a CLs social network
  • Age 18 or greater
  • Functional internet access.

Exclusion Criteria

  • Does not self-identify within a CLs social network
  • Is under the age of 18
  • Does not have functional internet access.

Outcomes

Primary Outcomes

COVID-19 attitudes

Time Frame: 4 weeks

Related to perceived susceptibility and preventive measures will be assessed through 3 survey instruments, based on 7-point Likert scale.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mark L Wieland

Chair, Community Internal Medicine

Mayo Clinic

Study Sites (2)

Loading locations...

Similar Trials

Community-Engaged Bidirectional Pandemic... | Clinical Trial